Details for 2018760168
Up to date per 06.04.2026
Actions
Details for 2018760168
Granted/Registered
European Patent
17.06.2020 A
24.01.2024 B1
11.08.2017
US
201762544277 P
C07D 498/04 20060101AFI20190216BHEP
Owner
Actuate Therapeutics Inc.1401 Foch St Suite 140 Fort Worth, TX 76107US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHRiemergasse 141010 WienAT
Inventor
ZHANG, YaminNo. 6 Taihe Road BDA Beijing 100176CN
Information about Fees